ezetimibe has been researched along with parthenolide in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (parthenolide) | Trials (parthenolide) | Recent Studies (post-2010) (parthenolide) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 612 | 5 | 323 |
| Protein | Taxonomy | ezetimibe (IC50) | parthenolide (IC50) |
|---|---|---|---|
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 4.525 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Han, N; Hu, X; Li, H; Li, J; Liang, B; Liu, W; Lu, C; Meng, J; Shi, L; Wang, C; Wang, X; Xing, D; Yang, S; Zeng, J; Zhang, R | 1 |
1 other study(ies) available for ezetimibe and parthenolide
| Article | Year |
|---|---|
First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.
Topics: Anticholesteremic Agents; Cholesterol; Ezetimibe; Filipin; Humans; Hypercholesterolemia; Hyperlipidemias; Membrane Transport Proteins; Molecular Docking Simulation; Sesquiterpenes | 2022 |